Research And Growth > Grants

Research Grants in Prematurity

2017 research grants are now available to researchers interested in addressing prematurity and improving neonatal health.

AMAG Pharmaceuticals, Inc. is committed to funding research aimed at reducing the risk of premature birth and improving the health of neonates and infants in the United States through its Prematurity Research Grants Program.

AMAG Pharmaceuticals awarded more than $300,000 in research grants in 2016 to the following principal investigators to support the important research they are conducting focused on prematurity prevention:

  • Mir Basir, M.D., an associate professor at the Medical College of Wisconsin who is researching the use of digital multimedia to enhance prematurity counseling;
  • Ruitang Deng, Ph.D., an associate professor of biomedical and pharmaceutical sciences at the University of Rhode Island’s College of Pharmacy who is leading a study focused on cholestasis and preterm birth;
  • Wendy Kuohung, M.D., an associate professor of obstetrics and gynecology at Boston University School of Medicine and a director of the reproductive endocrinology and infertility program at Boston Medical Center who is conducting research on progesterone effects on the oral microbiome and impact on preterm birth;
  • Donna Lambers, M.D., a Maternal Fetal Medicine specialist and director of perinatal research at TriHealth in Cincinnati, Ohio, who is researching urine metabolic profiling by mass spectrometry of pregnant women at risk for preterm birth;
  • Ramkumar Menon, Ph.D., an assistant professor in the department of obstetrics and gynecology at the University of Texas-Galveston who is conducting studies on feto-maternal exosome signaling in parturition.

The company is pleased to announce that it will again be funding research grants in prematurity in 2017 for a total of $300,000.* Consideration will be given to basic or clinical research in maternal, fetal and neonatal/infant health.  All proposals will be evaluated and the final awards will be determined based on scientific merit by an external review panel comprised of experts in the field. The panel will determine allocation of these funds, with no single recipient receiving more than $75,000 to allow for multiple grants to be provided.

Interested researchers should complete an application (to be posted on the SMFM, ACOG and AMAG websites) and submit by July 31, 2017 to Jennifer Gudeman, AMAG Medical Affairs, at jgudeman@amagpharma.com. Research awards are expected to be announced by October 31, 2017 with funds to be provided upon execution of a research grant contract, to ensure compliance with applicable regulations.

Download the 2017 AMAG Research Grant Application Form below.

2017 AMAG Research Grant application

*The funds from this grant program should be used exclusively for the research program and are not to be designated as general overhead.